Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides, Inc. (the ...

The project sets out to advance our understanding of how viruses enter cells, using the Marburg Virus (MARV) as a model, and to create ... Marburg virus, like Ebola virus, a member of the ...

A federal judge said the Trump administration’s deferred resignation program for federal workers could move forward, allowing the White House to advance a critical part of its plan to reduce the ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what makes REGN stock a compelling buy.

Jan. 2, 2025 — A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is ... Study Traces Ebola's Route ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Is the Sudan virus deadlier than Ebola? A key discovery explains how it clings to human cells. The Sudan virus, a close relative of Ebola, has a 50% fatality rate, but its mechanisms of cell ...

A suspected Ebola exposure at a Manhattan urgent-care facility had two patients rushed to the hospital by emergency workers in hazmat suits Sunday – but the disease was ruled out. The patients ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical ...